Non-alcoholic steatohepatitis
Pentoxifylline for the treatment of non alcoholic steatohepatitis: a randomized controlled trial
... of non-alcoholic steatohepatitis (NASH) is growing and current pharmacologic treatments are limited by side effects and inconsistent ...of steatohepatitis improved with pla- ...
10
Obesity related non alcoholic steatohepatitis and TGF β1serum levels in relation to morbid obesity
... TGF-β1 is just one of the many serum markers that could potentially be used for a non-invasive diagnosis of hepatic fibrosis. Matrix deposition proteins, matrix pro- duction and degradation enzymes, and other ...
5
Meta Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non alcoholic Steatohepatitis
... with reportable histology outcomes pre and post-treat- ment. Patients with diabetes and non-diabetics were in- cluded. Although changes in biochemical variables (AST ALT, hyperglycemia) and anthropometric ...
10
Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non alcoholic steatohepatitis
... Body and liver weight, serum parameters and he- patic glutathione content: After eight weeks of diet ad- ministration all animals exhibited an increase in their body weight. However, animals on CDD and CDD+PTX gained ...
6
Metabolic syndrome, non alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF)
... Secondly, non-fat cell content of visceral adipose tissue is more than that of subcutaneous adipose ...to non-fat cells, except for leptin and adiponectin, which are secret- ed mainly from ...
6
Epidemiology and natural history of non alcoholic liver disease (NAFLD)
... The authors summarize and update the most recent knowledge in the field of prevalence, natural history and incidence of Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic ...
5
Evaluación no invasiva de fibrosis en pacientes con esteatohepatitis: uso del puntaje de fibrosis en enfermedad por hígado graso no alcohólico (EHGNA)
... inglés: non-alcoholic fatty liver disease- NAFLD) es una enfermedad metabólica, que se carac- teriza por la presencia de macrovesículas de lípidos (triglicéridos) en el hepatocito, que puede asociarse ...
5
Alcoholic liver disease presents at advanced stage and progresses faster compared to non alcoholic fatty liver disease
... comparing alcoholic liver disease (ALD, black line) and non-alcoholic fatty liver disease (NAFLD, gray line) for cumulative pro- bability of development of ascites (A A A A A) and for patient ...
7
Anatomical cardiac alterations in liver cirrhosis: An autopsy study
... of alcoholic etiology, and heart failure representing the cause of death in 15%, only a slig- htly lower mortality than that caused by bleeding or infection in this group of ...
6
Chemical characterization of differential sensory compounds in alcoholic and non alcoholic lager beers: effects of dealcoholization process
... materials, alcoholic fermentation, or a wide range of chemical reactions such as lipid oxidation, Maillard reactions, Strecker degradation, aldol condensations of saturated aldehydes or degradation of bitter acids ...
260
Probiotics in non alcoholic fatty liver disease: which and when
... Non-alcoholic fatty liver disease (NAFLD) is a common and serious disease. Literature reports the central role of the gut-liver axis in the pathogenesis of NAFLD, and recently suggests that the microbiota ...
7
Primary care practitioners survey of non alcoholic fatty liver disease
... Background. The rising incidence of non alcoholic fatty liver disease (NAFLD) mirrors the epidemics of obesity and metabolic syndrome. Primary care practitioners (PCPs) are central to management of patients ...
8
Non alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community
... The diagnosis is based on establishing the presen- ce of fatty liver as well as the non-alcoholic nature of the disease. A liver biopsy is the gold standard, but it is invasive with associated risk. ...
6
Enfermedad de hígado graso no alcohólico: Un problema silente en la salud Costarricense
... grasa en el parénquima hepático que van desde el hígado graso no alcohólico, la esteatohepatitis no alcohólica abreviada comúnmente como NASH por su siglas en inglés, (Nonalcoholic steatohepatitis) hasta cirrosis ...
6
New Onset Diabetes and Non Alcoholic Fatty Liver Disease after Liver Transplantation
... their non-diabetic ...to non-diabetic subjects, with the exception of BMI, tryglicerides and GGT levels that were not significantly different between the aforementioned groups of patients (Table ...
9
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.
... Obesity is one of the most important public health problems worldwide, affecting both developed and emerging countries. It is characterized by an abnormal excess of white adipose tissue, which is a major risk factor for ...
15
Risk factors and predictors of non alcoholic fatty liver disease in Taiwan
... to non-alcoho- lic fatty liver disease can be correctly identified, they can be used in a noninvasive prognostic model to es- timate the degree of fat accumulation in ...
8
Enfermedad hepática por depósito de grasa no alcohólica en afecciones vasculares y oncológicas
... Introduction: Non alcoholic fatty liver disease (NAFLD) is one of the liver diseases more frequent in the ...with non alcoholic fatty liver ...steatosis, steatohepatitis, cancer, ...
14
Non invasive assessment of fibrosis in non alcoholic fatty liver disease (NAFLD)
... of non-inva- sive methodologies have sufficient to excellent diagnos- tic accuracy for the detection (or exclusion) of advanced fibrosis and cirrhosis, but none allow a follow-up of the fibrogenic evolution of ...
6
Altered clot kinetics in patients with non alcoholic fatty liver disease
... of non-alcoholic fatty liver disease (NAFLD) with an increased risk for cardiovascular ...1) non-cirrhotic NAFLD (n = 28) and 2) healthy control subjects (n = ...
8
